RobertJHayashiMD

Pediatric Hematology & Oncology • Saint Louis, MO

Professor of Pediatrics, Washington University St Louis

Join to view full profile

Dr. Hayashi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hayashi's full profile

Already have an account?

Office
1 Childrens Pl
# Div
Saint Louis, MO 63110
Phone+1 314-454-6018

Fax+1 844-621-4392

Summary

I am a Professor of Pediatrics the Division of Pediatric Hematology/Oncology and an attending physician in Hematology/Oncology and General Pediatrics at St. Louis Children’s Hospital. I am board certified in both Pediatrics and Pediatric Hematology/Oncology with clinical interests that include Bone Marrow Transplantation, Non-Hodgkin's Lymphoma and Post-transplant Lymphoproliferative disease (PTLD) and the long term consequences of cancer therapy. I am actively involved in institutional and national trials advancing the treatment of patients in these areas.

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1989 - 1992
Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1986 - 1989
Washington University in St. Louis School of MedicineClass of 1986, MD
Stanford UniversityBS, Biology, Departmental Honors, 1978 - 1982

Certifications & Licensure

MO State Medical License 1994 - 2025
MD State Medical License 1989 - 1994
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors for Cancer Castle Connolly, 2004-2024
America's Top Doctors Castle Connolly, 2004-2024
Rated a Top Ranked Oncology Program US News and World Report
Medical Excellence Award National Children's Cancer Society, 2013
Honorable Mention, School Wide Award 2007
Legacy Award National Children's Cancer Society, 2006
Medical School Wide Award 2006, 2016
Child Health Research Center Award 1992
Physician Scientist Award National Institute of Allergy and Infectious Diseases (NIAID), 1992
Departmental Honors, Department of Biology Stanford University, 1982
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Start of enrollment: 2001 Feb 01
Unknown status
Phase 3
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
Completed
Phase 3
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 25
Recruiting
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Start of enrollment: 2004 Apr 01
Active, not recruiting
Phase 3
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Start of enrollment: 2005 Nov 14
Completed
Phase 3
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission Start of enrollment: 2005 May 30
Completed
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer Start of enrollment: 2006 Feb 20
Completed
Phase 3
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor Start of enrollment: 2007 May 03
Completed
Phase 3
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Start of enrollment: 2006 Jun 01
Completed
Phase 2
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma Start of enrollment: 2007 Aug 06
Active, not recruiting
Phase 3
A Phase I/II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772, IND# 69896) in Children With Refractory Solid Tumors or Refractory Leukemias Start of enrollment: 2006 May 01
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Start of enrollment: 2006 Nov 06
Active, not recruiting
Phase 3
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Start of enrollment: 2006 Dec 26
Completed
Phase 3
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 1, Phase 2
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission Start of enrollment: 2007 Mar 01
Completed
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Start of enrollment: 2007 Jan 22
Active, not recruiting
Phase 3
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia Start of enrollment: 2007 Jan 01
Completed
Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases Start of enrollment: 2007 Dec 31
Completed
Phase 3
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin Start of enrollment: 2007 May 01
Completed
Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia Start of enrollment: 2008 Jan 01
Completed
Phase 2
Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System Start of enrollment: 2009 Feb 10
Completed
Phase 3
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia Start of enrollment: 2008 Apr 01
Completed
Phase 2
Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers Start of enrollment: 2008 Jun 02
Completed
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2009 Jan 01
Completed
Phase 2
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia Start of enrollment: 2009 Mar 09
Completed
Phase 3
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Start of enrollment: 2009 Mar 01
Completed
Phase 2
Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment Start of enrollment: 2009 Apr 01
Completed
Phase 1
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2006 Sep 25
Completed
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment Start of enrollment: 2009 Jun 01
Completed
Phase 1
Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia Start of enrollment: 2009 Jun 01
Terminated
Phase 1
Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma Start of enrollment: 2009 Sep 21
Completed
Phase 1, Phase 2
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Study of Blood Samples From Newborns With Down Syndrome Start of enrollment: 2009 Feb 23
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma Start of enrollment: 2005 May 30
Completed
Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2009 Dec 21
Completed
Phase 3
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features Start of enrollment: 2009 Sep 01
Completed
Phase 1
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Start of enrollment: 2010 Jan 01
Completed
Phase 2
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Childhood Cancer Survivor Study Start of enrollment: 1995 Jan 05
Recruiting
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2010 Jun 01
Completed
Phase 1
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia Start of enrollment: 2011 Feb 01
Completed
Phase 2
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease Start of enrollment: 2010 Sep 01
Completed
Phase 1
Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma Start of enrollment: 2010 Aug 09
Completed
Phase 1, Phase 2
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Start of enrollment: 2010 Oct 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia Start of enrollment: 2011 Jan 01
Completed
Phase 1
Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2010 Dec 01
Completed
Phase 1
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma Start of enrollment: 2011 May 01
Completed
Phase 1
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2011 Sep 01
Completed
Phase 2
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Start of enrollment: 2011 May 01
Completed
Not Applicable
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2011 Sep 01
Completed
Phase 1
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma Start of enrollment: 2012 Jan 01
Completed
Phase 2
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors Start of enrollment: 2012 Oct 26
Completed
Phase 1
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors Start of enrollment: 2012 Nov 14
Completed
Phase 1
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma Start of enrollment: 2013 Nov 01
Completed
Phase 1
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma Start of enrollment: 2013 Jan 31
Completed
Phase 1, Phase 2
Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas Start of enrollment: 2013 Sep 03
Completed
Phase 1
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Completed
Phase 2
Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors Start of enrollment: 2013 Apr 01
Completed
Phase 1
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2014 Mar 28
Completed
Phase 1, Phase 2
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies Start of enrollment: 2014 May 16
Completed
Phase 1, Phase 2
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors Start of enrollment: 2014 Sep 01
Completed
Phase 1
A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors Start of enrollment: 2015 Dec 11
Completed
Phase 1
Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors Start of enrollment: 2016 Aug 06
Withdrawn
Phase 2
Join now to see all

Publications & Presentations

PubMed

297 citations
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
Sally Arai, Mukta Arora, Tao Wang, Stephen R. Spellman, Wensheng He
Biology of Blood and Marrow Transplantation. 2015-02-01
1055 citations
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Kenneth Hung, Robert J. Hayashi, Anne Lafond-Walker, Charles J. Lowenstein, Drew M. Pardoll
The Journal of Experimental Medicine. 1998-12-21
50 citations
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
David T Teachey, Meenakshi Devidas, Brent L Wood, Zhiguo Chen, Robert J Hayashi
Journal of Clinical Oncology. 2022-07-01

Journal Articles

Paediatric oncology simulation training for resident education
Smink, GM, Jeffe, DB, Hayashi, RJ, Al-Hammadi, N, Fehr, JJ, BMJ Simulation, 9/7/2018
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen
Urbano-Ispizua A, Pavletic SZ, Flowers ME, Klein JP, Zhang MJ, Carreras J, Montoto S, Perales MA, Aljurf MD, Akpek G, Bredeson CN, Costa LJ, Dandoy C, Freytes CO, Fung..., Biol Blood Marrow Transplant, 1/15/2015
The Genomic Landscape of Juvenile Myelomonocytic Leukemia
Stieglitz, E and Taylor-Weiner, AN, Chang, TY, Gelston, LC, Wang, Y, Mazor, T, Esquivel, E, Yu, A, Seepo,S, Olsen,S, Rosenberg,M, Archambeault, SL, Abusin, G, Brown, P..., Nature Genetics, 1/12/2015
Neurocognitive Outcomes and School Performance in Solid Tumor Cancer Survivors Lacking Therapy to the Central Nervous System
Mohrmann, C, Henry, J., Hauff, M, Hayashi, RJ, J. Pers. Med., 1/1/2015
Second Solid Cancers After Allogeneic Hematopoietic Cell Transplantation Using Reduced Intensity/Non-myeloablative Conditioning Regimens
Ringden, O; Brazauskas, R, Wang, Z; Ahmed R; Atsuta,Y; Buchbinder, Y; Burns, LJ; Cahn, JY; Duncan, C; Hale, GA; Halter, J; Hayashi, RJ; Hsu, JW; Jacobsohn, DA; Kamble,..., Biology or Blood and Marrow Transplantation, 1/1/2014
Isolated Extramedullary Relapse of Pediatric Leukemia Following Stem Cell Transplantation: A Single Center Review
Dum, TM, Effinger, K, Witty, S, Mao, J, Barnes, Y, Shenoy, S, and Hayashi, RJ, Journal of Hematology and Transfusion, 1/1/2014
A Phase I Trial of Arsenic Trioxide Chemoradiotherapy in the Treatment of Infiltrating Astrocytomas of Childhood
Cohen K, Gibbs I, Fisher P, Hayashi, RJ, Macy ME, Gore L, Journal of Neuro-oncology, 1/15/2013
Differential effects of radiotherapy on risk of selected endocrinopathies among acute leukemia survivors: a report from the Childhood Cancer Survivor Study
Chow EJ, Liu W, Srivastava K, Leisenring WM, Hayashi RJ, Sklar CA, Stovall, M, Robison, LL, Backer, KS, Pediatric Blood and Cancer, 1/24/2012
Participation and self-management strategies of young adult cancer survivors
Berg C., Hayashi RJ, Occupational Therapy Journal of Research, 1/15/2012
Second Malignancies after Autologous Hematopoietic Cell Transplantation in Children
Danner-Koptik KE, Majhail NS, Brazauskas R, Wang Z, Buchbinder D, Cahn J, Dilley KJ, Frangoul HA, Gross TG, Hale, GA, Hayashi RJ, Hijiya N, Kamble RT, Lazarus HM, Mark..., Bone Marrow Transplantation, 1/10/2012
Low-dose chemotherapy and rituximab for post-transplant lymphoproliferative disease (PTLD): Children's Oncology Group report
Gross TG, Orjuela MA, Perkins SL, Park JR, Lynch JC, Cairo MS, Smith LM, Hayashi RJ, American Journal of Transplantation, 1/1/2012
Blueberry Muffin Rash and Respiratory Distress in a Late Preterm Infant
Farrell K, Hayashi RJ, Wambach K, Neoreviews, 1/1/2012
Late Onset Hearing Loss: A Significant Complication of Cancer Survivors Treated With Cisplatin Containing Chemotherapy Agents
Kolinsky DC, Hayashi SS, Karzon R, Mao J, Hayashi RJ, Journal of Pediatric Hematology/Oncology, 1/1/2010
Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphoma in Children and Adolescents
Gross TG, Hale, GA Wensheng, HE Camitta BM, Sanders JE, Cairo MS, Hayashi RJ, Termuhlen AM, Davies SM, Eapen M, Biology of Blood & Marrow Transplantation, 1/1/2010
Safety, Efficacy, and Pharmacology of Intravenous Busulfan in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Wall DA, Chan KW, Nieder ML, Hayashi RJ, Yeager AM, Kadota R, Przepiorka, DK, Mezzi, Kletzel M, for the Pediatric Blood and Marrow Transplant Consortium, Pediatric Blood and Cancer, 1/1/2010
The Late-Effects of Childhood Cancer on Occupational Performance and Quality of Life: A Pilot Study
Berg C, Neufeld P, Harvey J, Downes AC, Hayashi RJ, Occupational Therapy Journal of Research, 1/1/2009
Dental Health Among Long-term Survivors of Childhood
Kaste SC, Goodman PJ, Hayashi, RJ, Hudson, M, Leisenring, W, Paulino, A, Robison, L, Sklar, C, Stovall, M, Ng, MW, Baker KS, Cancer, 1/1/2009
Allogeneic Hematopoietic Cell Transplantation (HCT) in Hurler Syndrome using a Reduced Intensity Preparative Regimen
Hansen, MD, Filipovich, A H, Davies, SM, Mehta, P, Bleesing, J, Jodele, S, Hayashi, R, Barnes, Y, and Shenoy, S, Bone Marrow Transplantation, 1/1/2008
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies Following Single Fraction Total Body Irradiation
Druley TE, Hayashi RJ, Mansur DB, Zhang, J Barnes Y, Trinkaus K, Witty S, Thomas TE, Klein E, DiPersio JF, Adkins D, Shenoy S, Bone Marrow Transplantation, 1/1/2008
Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis
Baker KS, Filipovich AH, Gross TG, Grossman WJ, Hale GA, Hayashi RJ, Kamani NR, Kurian S, Kapoor N, Ringden O, Eapen M, Bone Marrow Transplantation, 1/1/2008
Cutaneous Effects of Thiotepa in Pediatric Patients Receiving High-dose Chemotherapy with Autologous Stem Cell Transplantation
Rosman IS;. Lloyd B M;. Hayashi RJ, MD, Bayliss SJ, Journal of the American Academy of Dermatology, 1/1/2008
Chronic Health Conditions and Function After Non-Hodgkin's Lymphoma in the Childhood Cancer Survivor Study
Bluhm E, Ronckers C, Meadows A, Mertens AC, Robison LL, Donaldson S, Meacham L, Hayashi RJ, Sklar CA, Kersun LS, Whitton J, Inskip P, Blood, 1/1/2008
Hearing Loss in Pediatric Oncology Patients Receiving Carboplatin Containing Regimens
Dean, JB, Hayashi, SS, Albert, CM, King, A, Karzon, R, Hayashi, RJ, Journal of Pediatric Hematology/Oncology, 1/1/2008
Physical Function and Attainment of Life Goals in Adult Survivors of Childhood and Adolescent Rhabdomyosarcoma: A Report from the Childhood Cancer Survivors Study
Punyko JA, Gurney JG, Baker KS, Hayashi RJ, Hudson MM, Lui Y, Robison LL, Mertens AC, Psycho-Oncology, 1/1/2007
Safety and Efficacy of Prolonged Cytomegalovirus Prophylaxis With Intravenous Ganciclovir in Pediatric Lung Transplant Recipients
Spivey JF, Jewell D, Sweet S, Storch GA, Hayashi, RJ, Huddleston CB, Danziger-Isakov LA, Pediatric Transplantation, 1/1/2007
Join now to see all

Books/Book Chapters

Pediatric Oncology
Chapter: "Lymphoproliferative Disorders and Malignancies Related to Immunodeficiencies"
Shiramizu, B, Wilkinson, R., Hayashi, R.Editors: Pizzo, P, Poplack, D.2010
Rudolph's Pediatrics
Chapter: Stem Cell Transplantation
Hayashi RJEdition 21st,2002

Lectures

Late Effects of Cancer Therapy: Challenges Beyond the Cure
Grand Rounds, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO - 11/3/2017
"Life-Long Health Care Partnerships"
St. Louis, MO - 1/1/2016
"Pediatric Cancer Clinical Trials"
St. Louis, MO - 1/1/2012
"Long-term Effects of Cancer Treatment in Children"
Siteman Cancer Center, St. Louis, MO - 1/1/2011
"Late Effects of Cancer Therapy: A Multidisciplinary Approach."
St. Louis Children's Hospital, St. Louis, MO - 1/1/2011
"Medical Care After Childhood Cancer Treatment"
1/1/2010
"Cooperative Group Clinical Trials in Childhood Cancer"
St. Louis Children's Hospital, St. Louis, MO - 1/1/2008
"Late Effects of Cancer Therapy"
St. Louis, MO - 1/1/2008
"Update on Pediatric Hematology"
Cape Girardeau, MO - 1/1/2008
"Late Effects of Pediatric Cancer Survivors"
Southern Illinois University School of Medicine, Springfield, IL - 1/1/2007
"Late Effects of BMT"
St. Louis, MO - 1/1/2005
"Childhood Cancer"
Washington University School of Medicine, St. Louis, MO - 1/1/2003
"Long Term Effects of Cancer Treatment"
St. Louis, MO - 1/1/2003
"Pediatric Stem Cell Transplantation: Its Current Status and Future Direction"
St. Louis, MO - 1/1/2002
"Late Effects of Childhood Cancer Survivors"
Maryville, IL - 1/1/2002
"Late Effects of Treatment in the Childhood Cancer Survivor"
Washington University School of Medicine, St. Louis, MO - 1/1/2002
"Update on Pediatric Bone Marrow Transplantation"
Columbia, MO - 1/1/2001
"Stem Cell Transplantation"
Christian Hospital Northeast, St. Louis, MO - 1/1/2001
"Post Transplant Lymphoproliferative Disease"
St. Louis, MO - 1/1/1999
"Pediatric Bone Marrow Transplantation"
St. Louis, MO - 1/1/1997
Join now to see all

Other

Book Review of Graft-Verses Host Disease, Nelson J. Chao, ed.
Hayashi, RJ, Doody's Review Club
1/1/1999
Book Review of Blood Stem Cell Transplantation, Jane N. Winter, ed.
Hayashi, RJ, Doody's Review Club
1/1/1997
Pediatric AML.
Hayashi RJ, EBM Solutions Guidelines for Health Care Providers and Consumers (online database), Issue 1: EBM Sol
Nashville, TN